This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Dr. Judy Walker, PhD
Chief Medical Officer at Arthex Biotech
Speaker

Agenda Sessions

  • Development of an Anti-microRNA Therapy for the Treatment of Myotonic Dystrophy Type 1 - The ArthemiR Clinical Trial

    , 2:00pm
    View Session

At this event

Prev
Next
Jane Wang, PhD
VP and Head of Delivery and Process Devlopment
Tessera Therapeutics

See Judy at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now